[{"Assets_0_Q2_USD":346370000.0,"CommonStockSharesOutstanding_0_Q2_shares":50733662.0,"EarningsPerShareBasic_2_Q2_USD":0.55,"EarningsPerShareBasic_1_Q2_USD":0.34,"EarningsPerShareDiluted_2_Q2_USD":0.52,"EarningsPerShareDiluted_1_Q2_USD":0.32,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":39300000.0,"NetIncomeLoss_2_Q2_USD":27665000.0,"NetIncomeLoss_1_Q2_USD":17368000.0,"StockholdersEquity_0_Q2_USD":229397000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":53026323.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":53223714.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":50345830.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":50530968.0,"Ticker":"SUPN","CIK":"1356576","name":"SUPERNUS PHARMACEUTICALS INC","OfficialName":"Supernus Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1557812380.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]